Fortress Biotech, Inc.
Home
About
Overview
Business Development
Management Team
Board of Directors
FAQ
Programs
Pipeline
Marketed Products
Publications
News & Media
Press Releases
Presentations
Events
Investors
Overview
News / Events
Company Info
Financial Info
Stock Data
Analyst Coverage
SEC Filings
Governance
Resources
Contact
Careers
FAQ
Accessibility Statement
All SEC Filings
Investors
Investors
Overview
News / Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Special Meeting Materials
Annual Meeting Materials
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Resources
FBIOP Announcements
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Special Meeting Materials
Annual Meeting Materials
Filing Type:
View All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
EFFECT
FWP
POS AM
PRE 14A
PX14A6G
REGDEX
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Date
Form
Description
PDF
XBRL
Pages
04/29/22
4
Statement of changes in beneficial ownership of securities
2
04/29/22
4
Statement of changes in beneficial ownership of securities
2
04/29/22
4
Statement of changes in beneficial ownership of securities
2
04/29/22
4
Statement of changes in beneficial ownership of securities
2
04/29/22
4
Statement of changes in beneficial ownership of securities
2
04/29/22
4
Statement of changes in beneficial ownership of securities
2
04/20/22
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
44
03/28/22
10-K
Annual report pursuant to Section 13 and 15(d)
Documents
EX-21.1
EX-23.1
EX-23.2
EX-31.1
EX-31.2
EX-32.1
EX-32.2
155
03/28/22
8-K
Current report filing
Documents
EX-99.1
9
02/14/22
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
4
Previous
15
16
17
18
19
20
21
22
23
24
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed